Results 241 to 250 of about 8,330,269 (304)

Overdose reversal through peer intervention: Findings from the naloxone prospective outcome research study (NalPORS) on the effectiveness of overdose response by people who use opioids in the United Kingdom and Sweden

Addiction, EarlyView.
Abstract Background/aims Take‐home naloxone (THN) programmes have been introduced in many European countries to provide non‐medically trained people who are likely to witness an opioid overdose, including people who use opioids, with a naloxone kit and training.
Nicola Metrebian, Teodora Dascal, Clare Mackie, Rose Tinch‐Taylor, Ben Carter, Joanne Neale, Mariana Gonzalez Utrilla, Ed Day, Joar Guterstam, Kirsten Horsburgh, Martin Kåberg, Mike Kelleher, Soraya Mayet, Josie Smith, Desiree Eide, Elin Holmén, Rebecca McDonald, Stephen Parkin, Henrik Thiesen, John Strang, NalPORS Research Team, Dean Acreman, Shabana Akhtar, Louise Aitken, Martin Anderson, James Cassidy, Sarah Cosgrove, Jo Grayer, Michelle Hughes, Louise Horn, Anika Miah, John Pratt   +31 more
wiley   +1 more source

Prolonged ventricular fibrillation treated with nifekalant in fulminant myocarditis following late-onset coronavirus disease 2019. [PDF]

BMJ Case Rep
Ojima S, Kubozono T, Kawabata T, Kawasoe S, Yamaguchi S, Enokida Y, Mukai S, Kanda D, Ohishi M.   +8 more
europepmc   +1 more source

Real‐world comparative effects of slow‐release oral morphine vs. methadone on healthcare use for opioid use disorder: A population‐based target trial emulation

Addiction, EarlyView.
Abstract Aims To examine the comparative effects of slow‐release oral morphine (SROM) vs. methadone for the treatment of opioid use disorder (OUD) on healthcare use. Design This retrospective cohort study emulated a target trial using electronic medical record data from Vancouver Coastal Health Authority linked with population‐based administrative ...
Vivienne Y. Zhou, Nadia Fairbairn, Jingxin Lei, Rupinder Brar, Paxton Bach, M. Eugenia Socias   +5 more
wiley   +1 more source

Coronavirus disease 2019-associated mucormycosis and cytomegalovirus infection: a case report. [PDF]

J Med Case Rep
Muqtadir J, Khan MA, Zaina F, Parvez SS, Das S, Boussios S.   +5 more
europepmc   +1 more source

Prescribed pharmaceutical alternatives initiative coinciding with reductions in unregulated street opioid use among young people who use drugs: An interrupted time series analysis

Addiction, EarlyView.
Abstract Background and aims In British Columbia, Canada, an initiative was implemented in 2020 to reduce overdose mortality by prescribing pharmaceutical opioids (primarily hydromorphone) as a substitute for the toxic unregulated drug supply. This study estimated changes in the level and trend of unregulated opioid use and non‐prescribed hydromorphone
Erica McAdam, Mohammad Karamouzian, Michael John Milloy, Carmen Verdicchio, Eric C. Sayre, Kanna Hayashi, Thomas Kerr, Kora DeBeck   +7 more
wiley   +1 more source

Comparative review of artificial intelligence for transcriptomic biomarker discovery in coronavirus disease 2019 (COVID-19). [PDF]

Brief Bioinform
Khoo LY, Dhillon SK.
europepmc   +1 more source

Effects of financial stress on drinking amount and price paid: Australian longitudinal household data

Addiction, EarlyView.
Abstract Background and aims This study estimated within‐household differences in alcohol consumption, alcohol expenditure, price paid per standard drink and the proportion of household expenditure spent on alcohol between periods with and without financial stress. It also estimated whether these outcomes differed in the year after households no longer
Alexandra Torney, Robin Room, Nicholas Taylor, Sarah Callinan   +3 more
wiley   +1 more source

Examining the state of telehealth for mental health and substance use care after the coronavirus disease 2019 pandemic: An integrative review. [PDF]

J Int Med Res
Marie SE.
europepmc   +1 more source

Methylenedioxymethamphetamine (MDMA)‐related fatal poisoning in Australia, 2016 to 2025: Trends, characteristics and toxicology

Addiction, EarlyView.
Abstract Aims To determine: (1) Population rates of fatal methylenedioxymethamphetamine (MDMA)‐related poisoning over the period 2016–2023, years with high closure rates in the National Coronial Information System (NDIS); (2) the case characteristics of known cases of fatal MDMA‐related poisoning, 2016–2025; and (3) whether there have been changes in ...
Shane Darke, Johan Duflou, Agata Chrzanowska, Michael Farrell, Julia Lappin, Amy Peacock   +5 more
wiley   +1 more source

Longitudinal Dynamics of Soluble NKG2D Ligands in Mild and Moderate Coronavirus Disease-2019. [PDF]

Yonago Acta Med
Nagamizu K, Nishikawa Y, Takata M, Yamaguchi K, Hashimoto Y, Morishita S, Shofiudin MA, Okada K, Kitaura T, Nakamoto M, Yamasaki A, Chikumi H.   +11 more
europepmc   +1 more source